Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma – Beyond the Abstract
IMDC criteria, liver metastasis, metastatic renal cell carcinoma, Renal cell carcinoma biological evolution, IMDC score, IMDC criteria, cabozantinib and ipilimumab-nivolumab combination.